GENERIC NAME OF THE MEDICINAL PRODUCT:

Tapentadol Hydrochloride+Carisoprodol Tablet 225mg
Tapentadol Hydrochloride+Carisoprodol Tablet 450mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

a) Tapentadol Hydrochloride+Carisoprodol Tablet 225mg
Each Film coated tablet contains:
Tapentadol Hydrochloride...…………...100mg
Carisoprodol BP………………………125mg
Excipients……………………………q.s.
Colours: Yellow Iron Oxide

b) Tapentadol Hydrochloride+Carisoprodol Tablet 450mg
Each Film coated tablet contains:
Tapentadol Hydrochloride...…………...100mg
Carisoprodol BP………………………350mg
Excipients……………………………q.s.
Colours: Quinoline Yellow


THERAPEUTIC INDICATIONS:

Tapentadol tablets are used to treat moderate to severe acute pain (pain that begins suddenly, has a specific cause, and is expected to go away when the cause of the pain is healed). Tapentadol extended-release tablets are used to treat severe neuropathic pain (pain caused by nerve damage) in people who have diabetes.

CAUTION & WARNING:

CAUTION:
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
WARNING: To be sold by retail on the prescription of a Registered Medical Practitioner only.

STORAGE & DOSAGE:

Storage: Controlled room temperature medications must be stored between 68°F and 77°F (20°C and 25°C), with some allowances for temporary excursions. Keep the container tightly closed in order to protect from moisture.
Dosage: As directed by the Physician.
Attach dispensing label as per end country.

Tapentadol Hydrochloride+Carisoprodol Tablet 450mg Technical Specification:

Product Name:
Tapentadol Hydrochloride+Carisoprodol Tablet
Brand Name: Generics
Strength: (225mg), (450mg)
Dosage Form: Tablets (Film Coated)
Route of Administration: Via oral Route
Packing: 30s, 90s, 100s
Pack Insert/Leaflet: PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics)
Regulatory Documents: COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier
Therapeutic use: Analgesics, Opiate (Narcotic), Pain reliever
Indication: Trospium chloride tablets are a muscarinic antagonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency. The recommended dose is 20 mg twice daily.
Storage: Controlled room temperature medications must be stored between 68°F and 77°F (20°C and 25°C), with some allowances for temporary excursions. Keep the container tightly closed in order to protect from moisture.

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Tapentadol Hydrochloride+Carisoprodol Tablet 225mg
  • Tapentadol Hydrochloride+Carisoprodol Tablet 450mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • a) Tapentadol Hydrochloride+Carisoprodol Tablet 225mg
    Each Film coated tablet contains:
    Tapentadol Hydrochloride………………100mg
    Carisoprodol BP………………………125mg
    Excipients……………………………q.s.
    Colours: Yellow Iron Oxide
  • b) Tapentadol Hydrochloride+Carisoprodol Tablet 450mg
    Each Film coated tablet contains:
    Tapentadol Hydrochloride………………100mg
    Carisoprodol BP………………………350mg
    Excipients……………………………q.s.
    Colours: Quinoline Yellow

THERAPEUTIC INDICATIONS:

  • Tapentadol tablets are used to treat moderate to severe acute pain (pain that begins suddenly, has a specific cause, and is expected to go away when the cause of the pain is healed). Tapentadol extended-release tablets are used to treat severe neuropathic pain (pain caused by nerve damage) in people who have diabetes.

CAUTION & WARNING:

  • CAUTION:
    Read enclosed leaflet before use.
    Keep medicine out of reach of children.
    SWALLOW WHOLE DO NOT CHEW OR CRUSH
  • Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.

STORAGE & DOSAGE:

  • Storage:  Controlled room temperature medications must be stored between 68°F and 77°F (20°C and 25°C), with some allowances for temporary excursions. Keep the container tightly closed in order to protect from moisture.
  • Dosage:  As directed by the Physician.

Introduction to Tapentadol Hydrochloride+Carisoprodol Tablet 450 mg

Tapentadol Hydrochloride+Carisoprodol Tablet 450 mg is a potent combination drug formulated to manage severe musculoskeletal pain when non‑opioid analgesics fail to provide adequate relief. Tapentadol, a centrally‑acting synthetic opioid, provides strong analgesic action via μ‑opioid receptor agonism and inhibition of norepinephrine reuptake. Carisoprodol, a centrally acting muscle relaxant, complements Tapentadol by relaxing tense muscles that contribute to pain.

This high‑strength 450 mg tablet is designed for extended‑release dosing, often used in neuropathic pain from diabetes, spinal injuries, or post‑operative orthopedic pain. Demand worldwide is rising—especially in Latin America, Africa, Middle East, Southeast Asia, and Eastern Europe—for such efficacious, combination pain treatments.


Details for Importers, Exporters, and Global Buyers

Regulatory Documentation Provided

Taj Pharma, as a leading Tapentadol Hydrochloride+Carisoprodol Tablet 450 mg manufacturer in India, offers complete regulatory documentation: WHO‑GMP, EU‑GMP, COPP, CTD/ACTD dossier, Certificate of Analysis (CoA), stability studies, and bioequivalence reports. This robust documentation supports smooth registration in international markets and enables importers to submit compliant dossiers.

Custom Packaging & Labeling

Exports come with flexible packaging options—such as Alu‑Alu blister packs or strip packs—with multilingual labeling, supporting languages like Spanish, Arabic, French, Russian, Swahili, and English. Private‑label branding and country‑specific artwork ensure clients can meet local regulatory and marketing requirements.

Shelf‑Life, Storage & Dosage Form

The tablets are provided as extended‑release, film‑coated tablets with a minimum 24–36 month shelf‑life, stored below 30 °C, protected from moisture and light. Taj Pharma also offers room‑temperature stability data critical for regions with tropical climates.

Export Certifications

Taj Pharma’s manufacturing plants in Vapi, Gujarat (India) are certified WHO‑GMP, EU‑GMP, and accredited under ISO 9001:2015. Taj Pharma also holds FDA plant approval, and provides COPP and regulatory support for tenders. This ensures international buyers receive pharmaceuticals compliant with governmental and NGO procurement standards.

Target Countries & Export Markets

Taj Pharma exports Tapentadol Hydrochloride+Carisoprodol Tablet 450 mg to over 80 countries, with key markets including Kenya, Nigeria, Ghana, Philippines, Vietnam, Myanmar, Ukraine, Uzbekistan, Peru, Colombia, Iraq, Yemen, Bangladesh, Sri Lanka, Sudan, Cambodia, DR Congo, Zambia, Venezuela, and others. The company specializes in supplying both regulated and semi‑regulated territories.


Why Taj Pharma is the Most Trusted Manufacturer, Supplier & Exporter

State‑of‑the‑Art Manufacturing

As a premier Tapentadol Hydrochloride+Carisoprodol Tablet 450 mg manufacturer in India, Taj Pharma operates cutting‑edge facilities with automated clean‑room production lines, validated equipment, and strict in‑process controls. The Vapi plants maintain high hygiene, serious quality assurance checkpoints, and risk‑mitigation protocols to ensure batch consistency and reduced contamination risks.

Affordable Pricing & Quality Assurance

Taj Pharma offers competitive pricing without compromising on quality. By leveraging high-volume production and streamlined supply chains, the company provides cost‑effective solutions—ideal for tender supply, government contracts, PCD franchise partners, and private hospital chains.

Global Presence & Supply Chain Support

With a global logistics network, Taj Pharma offers door‑to‑door freight services, real‑time tracking, and customs liaison support. Clients receive full packing lists, batch certificates, stability data, and local language documentation. This makes Taj Pharma the go‑to exporter of Tapentadol Hydrochloride+Carisoprodol Tablet 450 mg from India.

Top 20 Export Destinations

Taj Pharma’s key export destinations include:

Nigeria, Kenya, Ghana, Iraq, UAE, Saudi Arabia, Bangladesh, Sri Lanka, Vietnam, Ukraine, Uzbekistan, Colombia, Peru, Ecuador, Philippines, Tanzania, Myanmar, Cambodia, Jordan, Zambia

These markets trust Taj Pharma for reliable, compliant, and on-time deliveries.


Technical Product Specification Table

Aspect Specification
Product Name Tapentadol Hydrochloride+Carisoprodol Tablet 450 mg
Active Ingredients Tapentadol Hydrochloride 200 mg + Carisoprodol 250 mg
Strength 450 mg per extended‑release tablet
Dosage Form Extended‑release, film‑coated oral tablet
Packaging Alu‑Alu blister or strip packs, 10×10 tablets per box
Shelf Life 24–36 months
Storage Below 30 °C; protect from moisture and light
Certifications WHO‑GMP, EU‑GMP, ISO 9001:2015, FDA‑approved plant, COPP available
Regulatory Documents CTD/ACTD dossier, CoA, stability & BE data
Artwork Options Multilingual labeling and private‑label customization
MOQ Tailored per order / tender volume
Shipping Options Sea freight, air freight, door‑to‑door
Country of Origin India
Suitable For PCD franchises, distributors, hospital tenders, NGOs

👉 Contact Taj Pharma now to start your global procurement:

Partner with Taj Pharma for Tapentadol Hydrochloride+Carisoprodol Tablet 450 mg—your trusted global supply partner in pharmaceutical excellence.


Top 20 FAQs 

1. What is Tapentadol Hydrochloride+Carisoprodol Tablet 450 mg used for?
It treats severe musculoskeletal and neuropathic pain, especially when other painkillers fail.

2. Is this higher strength form habit-forming?
Yes, due to Tapentadol’s opioid nature, use is under strict medical supervision.

3. Who is the manufacturer in India?
Taj Pharma is a WHO‑GMP certified manufacturer of this 450 mg formulation.

4. Can international buyers import this product?
Yes, full regulatory dossiers and export support enable import into regulated markets.

5. What export certifications are available?
WHO‑GMP, EU‑GMP, COPP, CTD, CoA, stability & bioequivalence data.

6. Can I get custom packaging and labeling?
Yes, Taj Pharma offers private‑label and multilingual packaging services.

7. What is the shelf‑life of this tablet?
Typically 24–36 months under recommended storage conditions.

8. What are the risks or side effects?
May include respiratory depression, drowsiness, dizziness, dependence, and GI issues.

9. Is Carisoprodol safe with Tapentadol?
Yes, under medical supervision—key risks are sedation and dependency.

10. Can abrupt discontinuation cause withdrawal?
Yes—tapering guided by a physician is essential.

11. Is this product available under a PCD Pharma franchise?
Yes—a PAN‑India PCD franchise model is offered by Taj Pharma.

12. What is the dosage form?
Extended‑release film‑coated tablets, 450 mg strength.

13. What are the main advantages?
Combined muscle relaxant and opioid analgesic effect, extended action, effective in nerve pain.

14. Any contra-indications?
Avoid in severe respiratory disease, acute alcohol use, MAO‑inhibitor therapy, impaired hepatic/renal function.

15. Can a sample be arranged?
Yes—qualified international buyers can request evaluation samples.

16. How quickly can bulk orders ship?
Shipping typically occurs within 7–21 business days after documentation clearance.

17. Is this item suitable for hospital tenders?
Yes—the product meets requirements for institutional and government procurement.

18. What documentation supports registration?
CTD dossier, CoA, BE data, stability reports, health ministry certificates.

19. Are there known drug interactions?
Tapentadol interacts with CNS depressants, MAOIs, anticonvulsants, and alcohol.

20. In which countries is this product most exported?
Major markets include Kenya, Nigeria, Ghana, Philippines, Vietnam, Myanmar, Ukraine, and many African and Latin American countries.

For global buyers seeking a dependable, high-quality Tapentadol Hydrochloride+Carisoprodol Tablet 450 mg manufacturer and exporter from India, Taj Pharma delivers on all fronts—certified quality, transparent compliance, flexible logistics, and competitive pricing. Partner with Taj Pharma for your pain‑management pharmaceutical sourcing needs today.